Grifols

Grifols is a global healthcare company, founded in Barcelona in 1909, dedicated to enhancing the health and well-being of people worldwide. As a leader in essential plasma-derived medicines and transfusion medicine, we develop, produce, and deliver innovative healthcare services and solutions across more than 110 countries. Our innovation in plasma-based therapies and other biopharmaceuticals is driven by patient needs and our expanding understanding of numerous chronic, rare, and prevalent diseases, some of which are life-threatening, with the goal of improving quality of life. Grifols is dedicated to addressing conditions across a wide range of therapeutic areas, including immunology, hepatology and intensive care, pulmonology, hematology, neurology, and infectious diseases. With over 23,000 employees in more than 30 countries and regions, we are dedicated to a sustainable business model that establishes the benchmark for continuous innovation, quality, safety, and ethical leadership in the industry. Our operations generate a positive social and economic impact in the regions where we work, creating employment and producing wealth. People are central to our mission, and we aim to foster an inclusive, diverse, fair, and equitable society. Maintaining and encouraging a workforce that mirrors this principle leads to stronger professional relationships and enables us to deliver our utmost to patients, donors, and customers. In 2025, Grifols was recognized by TIME as one of the 'World's Best Companies' for the third consecutive year, confirming our commitment to excellence. Additionally, Forbes listed us among the "Best World Employers 2025," highlighting our commitment to cultivating an inclusive and supportive work environment for everyone. To ensure a positive community and respectful communication overall, kindly consider our community guidelines.